Document:

Document

EXHIBIT 4.13

DESCRIPTION OF THE REGISTRANT’S SECURITIES
REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES
EXCHANGE ACT OF 1934
Cisco Systems, Inc. (“Cisco,” “we,” “our,” or “us”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock.
DESCRIPTION OF CAPITAL STOCK
The following summary of the terms of our capital stock is based upon our Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) and our Amended and Restated Bylaws (the “Bylaws”). The summary is not complete and is qualified by reference to our Certificate of Incorporation and Bylaws, each of which are filed as exhibits to the Annual Report on Form 10-K of which this exhibit is a part, and are incorporated by reference herein. We encourage you to read our Certificate of Incorporation, our Bylaws and the applicable provisions of the Delaware General Corporation Law (“DGCL”) for additional information.
Authorized Shares of Capital Stock
Our authorized capital stock consists of twenty (20) billion shares of common stock, $0.001 par value, and five (5) million shares of preferred stock, $0.001 par value. The outstanding shares of our common stock are duly authorized, validly issued, fully paid, and nonassessable.
Listing
Our common stock is listed and principally traded on The Nasdaq Stock Market LLC under the symbol “CSCO.”
Voting Rights
Each holder of shares of our common stock is entitled to one (1) vote for each share held of record by such holder on the applicable record date on all matters submitted to a vote of stockholders. Pursuant to our Certificate of Incorporation, stockholders do not have the right to vote cumulatively. 
Dividend Rights
Subject to any preferential dividend rights granted to the holders of any shares of our preferred stock that may at the time be outstanding, holders of our common stock are entitled to receive dividends as may be declared from time to time by our board of directors out of funds legally available therefor.
Rights upon Liquidation
Subject to any preferential rights of outstanding shares of preferred stock, holders of our common stock are entitled to share pro rata, upon any liquidation or dissolution of Cisco, in all remaining assets legally available for distribution to stockholders.
Other Rights and Preferences
Our common stock has no sinking fund, redemption provisions, or preemptive, conversion, or exchange rights. Special meetings of stockholders may be called by stockholders holding shares representing not less than 10% of the voting power of Cisco on the record date of the related special meeting. Holders of our common stock may also act by unanimous written consent.
Transfer Agent and Registrar
Computershare Investor Services is the transfer agent and registrar for our common stock.
Certain Anti-Takeover Effects
Certain provisions of our Certificate of Incorporation and Bylaws may be deemed to have an anti-takeover effect.
Advance Notice Requirements for Shareholder Proposals and Director Nominations. Our Bylaws provide advance notice procedures for shareholders seeking to bring business before our annual meeting of shareholders or to nominate candidates for election as directors at our annual meeting of shareholders and specify certain requirements regarding the form and content of a shareholder’s notice. These provisions might preclude our shareholders from bringing matters before our annual meeting of shareholders or from making nominations for directors at our annual meeting of shareholders if the proper procedures are not followed. 
Additional Authorized Shares of Capital Stock. The additional shares of authorized common stock and preferred stock available for issuance under our Certificate of Incorporation, could be issued, at such times, under such circumstances and with such 

terms and conditions as to impede a change in control.
Exclusive Forum. Our Bylaws provide that unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware, to the fullest extent permitted by law, is the sole and exclusive forum for (a) any derivative action or proceeding brought on our behalf, (b) any action asserting a claim of breach of a fiduciary duty owed by, or other wrongdoing by, any director, officer, stockholder, employee or agent of us to us or our stockholders, (c) any action asserting a claim against us arising pursuant to the DGCL, our Certificate of Incorporation or Bylaws or as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware, (d) any action to interpret, apply, enforce or determine the validity of our Certificate of Incorporation or Bylaws, or (e) any action asserting a claim against us that is governed by the internal affairs doctrine. Our Bylaws further provide that unless we consent in writing to the selection of an alternative forum, to the fullest extent permitted by law, the federal district courts of the United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended. Nothing in the exclusive forum provisions of our Bylaws affects suits brought to enforce a duty or liability created by the Securities Exchange Act of 1934, as amended, or any other claim for which the federal courts have exclusive jurisdiction.
Business Combinations with Interested Stockholders. In general, Section 203 of the DGCL prohibits a publicly held Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. We have opted out and are not subject to the provisions of Section 203 of the DGCL.Exhibit 10.1

 

 

 

June 22, 2021

 

Mr. Gary Loffredo

Chief Operating
Officer

Cinedigm Corporation

237 West 35th Street, Suite 605

New
York, New York 10001

 

Re: Loan No. 372001061

 

Dear Mr. Loffredo:

 

Reference is made
to that certain Loan, Guaranty and Security Agreement dated as of March 30, 2018, entered into between Cinedigm Corp. (“Borrower”),
the other Loan Parties (together with Borrower, collectively “Loan Parties”), and East West Bank (“Bank”),
together with any and all amendments, modifications, riders and attachments thereto (collectively, the “Loan Agreement”) governing
certain financial accommodations which Bank has extended to Borrower. All capitalized terms used in this letter shall have the meanings
given to them in the Loan Agreement, unless specifically defined herein. Under the terms of the loan documents, your loan is about to
mature on June 30, 2021.

 

In order to provide
you smooth uninterrupted service under your credit facility while your request for a maturity extension of your loan to June 30,
2022 is being reviewed, we are pleased to inform you that you have been approved for an extension of the maturity date of your loan
to September 28, 2021.

 

This extension
should allow ample time for you to assemble and for us to review the financial information needed to consider your request for a renewal
and maturity extension to June 30, 2022.

 

We appreciate your business
and look forward to working with you on your request to renew this loan.

 

Very truly yours,

 

	/s/
    Robert Mostert, FVP	 
	Robert Mostert, FVP	 

 

 

 

 

135 N. Los Robles Ave.,
6th Floor, Pasadena, CA 91101 • Tel. 626.768.6924 • Fax 626.243.9810 • Nasdaq: EWBCexhibit101-nmihxapollitz

EXHIBIT 10.1        September 9, 2021  Adam Pollitzer  2100 Powell Street, 12th Floor  Emeryville, CA 94608      Dear Adam:  We are pleased and excited to memorialize the terms of your continued employment with NMI  Holdings, Inc. (the “Company”) on the terms and subject to the conditions set forth in this letter (this  “Letter”).    1. Terms of Employment    At-Will Employment.  This Letter is not a contract guaranteeing employment for any specific  duration.  Rather, your employment with the Company is, and will continue to be, on an at-will basis.  As  an at-will employee, both you and the Company have the right to terminate your employment at any time  with or without cause.    Transition Date; Title; Duties; Reporting.  Commencing as of January 1, 2022 (the “Transition  Date”), your title will be President and Chief Executive Officer and you will report directly to the Board  of Directors of the Company (the “Board”).  As President and Chief Executive Officer, you will have  authorities, powers, duties and responsibilities as are commensurate with your role and as are customarily  exercised by a person in your role in a company of the size and nature of the Company, as set forth on  Exhibit A hereto, or as otherwise directed by the Board.  You will dedicate all of your business time to the  business and affairs of the Company.  You will be based in the Company’s Emeryville, CA office, subject  to reasonable business travel at the Company’s request.     If your employment with the Company terminates for any reason before the Transition Date, this  Letter will automatically terminate and be of no further force or effect, and neither of the parties will have  any obligations hereunder; provided, however, in such event the terms and conditions of the offer letter  dated February 1, 2017 by and between you and the Company will remain in full effect.    2. Compensation and Benefits      Annual Base Salary.  Commencing on the Transition Date, during your employment, you will be  entitled to be paid an annual base salary at the rate of $800,000 per year (your “Annual Base Salary”),  payable at times consistent with the Company’s general policies regarding compensation of employees, as  in effect from time to time.    Annual Discretionary Bonus.  Commencing on the Transition Date, during each fiscal year of  your employment, you will be eligible to earn an annual discretionary bonus (your “Annual Bonus”),  with a target Annual Bonus opportunity of 150% of your Annual Base Salary, payable in accordance with  the Company’s customary practices with respect to the payment of discretionary bonuses, as in effect  from time to time.  Your Annual Bonus may be based upon the attainment of performance metrics  determined by the Board or the Compensation Committee of the Board (the “Committee”).  The amount  of any Annual Bonus actually paid to you will be determined by the Committee in its sole discretion.   

 

EXHIBIT 10.1      Except as provided herein, you must be employed by the Company or one of its subsidiaries at the time of  payment to receive your Annual Bonus.     Discretionary Equity Compensation.  You will be eligible to receive a 2022 annual equity award  under the Company’s Amended and Restated 2014 Omnibus Incentive Plan, or any successor plan.  Your  2022 annual equity award will have a target grant date fair value equal to $3,000,000, 50% of which is  expected to be in the form of time-vesting restricted stock units and the remaining 50% of which is  expected to be in the form of performance-vesting restricted stock units.  The terms and conditions of  such awards, including the grant date, vesting schedules and applicable performance metrics, will be  determined by the Committee and set forth in the applicable award agreements.    Commencing with the 2023 fiscal year, during your employment, you will continue to be eligible  to receive equity-based compensation awards from the Company.  The number and type of equity-based  compensation awards granted to you, the frequency of the grant, and the terms of such equity-based  awards will be established by the Board or the Committee.    Employee Benefits.  During your employment, you will continue to be eligible to participate in  any health, welfare and retirement benefit programs adopted and maintained by the Company for its  employees, subject to the terms and limitations of the applicable plan and the Company’s ability, in its  sole discretion, at any time and from time to time, to change or terminate any of its employee benefit  plans, programs or policies.    Executive Cash Allowance.  During your employment, you will continue to be eligible to  participate in the Company’s Executive Cash Allowance program as in effect from time to time, subject  to the terms and limitations of the Executive Cash Allowance program and the Company’s ability, in its  sole discretion, at any time and from time to time, to change or terminate the program.  Under the terms  of the Executive Cash Allowance program as in effect as of the date hereof, commencing on the  Transition Date, you will be eligible to receive a fixed cash amount of $38,400 per year in lieu of  individualized perquisites, payable at times consistent with the Company’s payroll practices, as in effect  from time to time.      Paid Time Off.  During your employment, you will continue to receive 30 days of paid time off  per year, pro-rated on a calendar year basis.     Expense Reimbursement.  During your employment, the Company will continue to reimburse you  for all reasonable expenses incurred in your performance of your duties in accordance with the  Company’s expense reimbursement policies applicable to similarly situated executives of the Company  from time to time.    3. Severance Benefits    During your employment with the Company, you will remain eligible to participate in the  Company’s Severance Benefit Plan (the “Severance Plan”) at the level of “EVPs, President & CEO  (without employment agreement).”  In addition, if you are terminated without “Cause” (as defined  below), not in connection with a change in control of the Company, such Severance Plan will apply to  you under Section I.4 and you will be eligible for “Severance Pay” (as defined under the Severance Plan)  in accordance with, and subject to the terms and conditions of the Severance Plan. “Cause”, for purposes  of this Letter, means: (i) your conviction of, or plea of guilty or nolo contendere by for committing a  felony under federal law or the law of the state in which such action occurred, (ii) your willful and  

 

EXHIBIT 10.1      deliberate failure to perform your employment duties in any material respect, (iii) dishonesty in the course  of fulfilling your employment duties, or (iv) a material violation of the Company’s ethics and compliance  program.   You will also remain eligible to participate in the Company’s Change in Control Severance  Benefit Plan (the “CIC Plan”).  On or as soon as reasonably practicable following the Transition Date,  your participation letter under the CIC Plan, dated as of May 10, 2017, will be amended to provide that  your Severance Multiple (as defined in the CIC Plan) will be 2x and your COBRA Period (as defined in  the CIC Plan) will be 24 months.    4. Restrictive Covenants    Return of Company Property.  Upon a termination of your employment for any reason, you will  promptly return to the Company any keys, credit cards, passes, equipment, computers, records, files,  documents or material, or other property belonging to the Company, and you will also return all writings,  files, records, correspondence, notebooks, notes and other documents and things (including any copies  thereof) containing confidential information or relating to the business or proposed business of the  Company or its affiliates or containing any trade secrets relating to the Company or its affiliates, in each  case without retaining copies in any form, except you may retain any personal diaries, calendars,  rolodexes or personal notes or correspondence.  For purposes of the preceding sentence, the term “trade  secrets” will have the meaning ascribed to it under the Uniform Trade Secrets Act. You agree to represent  in writing to the Company upon termination of your employment that you have complied with this  paragraph.    Nondisparagement.  You agree that, following your termination of employment, you will not  make any public statements which materially disparage the Company.  The Company agrees to instruct its  directors and executive officers not to make any public statements which materially disparage you.   Notwithstanding the foregoing, nothing in this Letter will prohibit you, or is to be construed as precluding  you, from making truthful statements when required by order of a court or other governmental or  regulatory body having jurisdiction or to enforce any legal right including, without limitation, the terms of  this Letter.    Confidential Information.  You acknowledge that you will have knowledge of certain trade  secrets of the Company and its business plans and prospects.  You will hold in a fiduciary capacity for the  benefit of the Company all secret or confidential information, knowledge or data relating to the Company  and its businesses or prospective businesses, including, without limitation, any trade secrets, research,  secret data, business methods, operating procedures or programs which will have been obtained by you in  connection with your services to the Company or any affiliates thereof and which will not be or become  public knowledge (other than by acts by you in violation of this Letter) (collectively, the “Trade Secrets  and Confidential Information”); provided, however, that you and the Company acknowledge and agree  that you will be required to disclose Trade Secrets and Confidential Information to third parties in  performing services for the Company under this Letter, which you may do only to the extent required, as  determined within your reasonable discretion.  After termination of your services with the Company for  any reason, you will not, without the prior written consent of the Company or as may otherwise be  required by law or legal process, communicate or divulge any such information, knowledge or data to  anyone other than the Company and those designated by it.  You agree to promptly notify the Company’s  General Counsel via telephone and email as soon as you learn that you may be asked to divulge any Trade  Secrets and Confidential Information in any legal proceeding so that the Company may take steps, if  necessary, to protect its interests concerning the Trade Secrets and Confidential Information.     Nonsolicitation.  You agree that, while you are employed by the Company and during the one- 

 

EXHIBIT 10.1      year period following the cessation of your employment for any reason, you will not directly or indirectly  (i) solicit any individual who is, on the date of termination (or was, during the six-month period prior to  the date of termination), employed by the Company or any of its affiliates to terminate or refrain from  renewing or extending such employment or to become employed by or become a consultant to any other  individual or entity other than the Company or its affiliates, or (ii) solicit any investor or prospective  investor in the Company or any business contact introduced to you in connection with your employment  by the Company hereunder to curtail or cease doing business with the Company or any of its affiliates.    Severability; Blue Pencil.  You acknowledge and agree that you have had the opportunity to seek  advice of counsel in connection with this Letter and the restrictive covenants contained herein are  reasonable in geographical scope, temporal duration and in all other respects.  If it is determined that this  paragraph or any of the paragraphs titled “Nondisparagement,” “Confidential Information,”  “Nonsolicitation,” or “Equitable Remedies” (such paragraphs, the “Restrictive Covenants”) is invalid or  unenforceable, the remainder of the provisions of such paragraphs will not thereby be affected and will be  given full effect, without regard to the invalid portions.  If any court or other decision-maker of competent  jurisdiction determines that any covenant or covenants in this Letter is unenforceable because of the  duration or geographic scope of such provision, then after such determination becomes final and  unappealable, the duration or scope of such provision, as the case may be, will be reduced so that such  provision becomes enforceable, and in its reduced form, such provision will be enforced.    Whistleblower Rights.  Notwithstanding the foregoing, nothing in this Letter limits your ability to  exercise any legally protected whistleblower rights or communicate with any federal, state, or local  governmental agency, commission or body, including the Equal Employment Opportunity Commission,  the National Labor Relations Board, the Occupational Safety and Health Administration, and the  Securities and Exchange Commission (collectively, a “Governmental Agency”), or self-regulatory  organization or otherwise participate in any investigation or proceeding that may be conducted by any  Governmental Agency or self-regulatory organization, without notice to the Company or its General  Counsel.    5. Section 409A Compliance    Any amounts payable under this Letter are intended to be exempt or excluded from the  application of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations  promulgated thereunder (“Section 409A”), or are otherwise intended to avoid the incurrence of tax  penalties under Section 409A, and, with respect to amounts payable under this Letter that are subject to  Section 409A, this Letter will in all respects be administered in accordance with Section 409A.    6. Miscellaneous.    Governing Law.  This Letter will be governed, construed, and interpreted under the laws of the  State of California, without giving effect to any conflict of laws provisions.    Arbitration.  Any disputes concerning your employment, the terms of your employment, the  termination of your employment, your relationship with the Company, or the interpretation and  application of this offer will be resolved on an individual basis through binding arbitration in accordance  with the Mutual Agreement to Arbitrate signed by you as a condition of employment, the terms of which  are incorporated herein.  Actions for temporary or preliminary injunctive relief (including claims for a  temporary protective order), in aid of arbitration or to maintain the status quo pending arbitration, may be  filed in a court with jurisdiction over the matter in accordance with applicable law.  

 

EXHIBIT 10.1        Company Policies.  You agree to comply fully with all policies and procedures in effect for  employees, including but not limited to, the Employee Handbook, the Business Conduct Policy and any  other memoranda and communications applicable to you pertaining to policies, procedures, rules and  regulations, in each case as currently in effect and as may be amended from time to time.     Withholding.  All payments and benefits provided for in this Letter are subject to withholding for  applicable income and payroll taxes or otherwise as required by law.     Entire Agreement.  This Letter constitutes the entire agreement between you and the Company  regarding your employment with the Company and, effective as of the Transition Date, supersedes any  and all oral or written employment or compensation agreements between you and the Company or its  affiliates regarding the subject matter of this Letter, including, without limitation, the offer letter between  you and the Company dated February 1, 2017.    Please confirm acceptance of this offer by signing below and returning a signed copy of this  Letter to me.      [Signature Page Follows]  

 

      Sincerely,      /s/ Bradley M. Shuster  Bradley M. Shuster  Executive Chairman    Acknowledged and Agreed    /s/ Adam Pollitzer  Adam Pollitzer        

 

    Exhibit A    President and CEO   Sets strategic direction in conjunction with Board   Responsible for strategy execution, operational and financial results    Operational Responsibility:    Financial results of the company   Strategic planning   Leadership of Executive Committee   Development of leadership team   Leads company operations   Officers and employees report to him or her   Maintain a positive and safe work environment   Regulatory compliance  Board Interactions:   Serve as member of the Board   Coordinate with Executive Chairman in shaping board agendas    Prepare and communicate Board materials   Communicates with all directors on key issues outside of board meetings   Seek approval on major investments, M&A, etc.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}]]